Month: January 2026

Technip Energies awarded two large contracts by BPCL for new units at Bina and Mumbai refineries in India

Written by Customer Service on January 7, 2026. Posted in Public Companies.

Technip Energies – BPCLTechnip Energies awarded two large contracts by BPCL for new units at Bina and Mumbai refineries in IndiaTechnip Energies (PARIS:TE) has been awarded two large(1) contracts by Bharat Petroleum Corporation Limited (BPCL) for key projects at its Bina refinery in Madhya Pradesh and Mumbai refinery in Maharashtra, India. The first contract covers Engineering, Procurement, Construction and Commissioning (EPCC) for new polypropylene and Butene-1 units at the Bina refinery in Madhya Pradesh. The units will produce 550 KTPA(2) of polypropylene and 50 KTPA of Butene-1, essential building blocks for widely used products such as packaging materials, pipes and automotive components. This contract is part of BPCL’s Bina Petchem and Refinery Expansion Project, encompassing refinery capacity increase as well as...

Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections

Written by Customer Service on January 7, 2026. Posted in Public Companies.

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, today announced an agreement with Prokaryotics Inc., a privately held US-based biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs. The collaboration aims to jointly develop a first-in-class broad-spectrum antifungal for the treatment of severe invasive infections. The collaboration is focused on a program of antifungal molecules with a novel mode of action, addressing the critical unmet need of patients with invasive infections caused by strains of Candida, Aspergillus, and rare molds. The joint efforts aim to deliver a clinical candidate, which will then be further progressed...

Lerøy Seafood Group ASA: Trading update Q4 2025

Written by Customer Service on January 7, 2026. Posted in Earnings Releases And Operating Results.

HARVEST VOLUMES OF SALMON AND TROUT Total harvest volume of salmon and trout for Q4 2025 was 49,300 GWT, compared to 56,800 GWT in Q4 2024. For the full year 2025, harvested volume of salmon and trout was 195,600 GWT compared to 171,200 GWT in 2024. These figures exclude harvest volumes from Scottish Seafarms. Harvest volumes by region/company for Q4 2025 (Q4 2024), measured in 1,000 GWT: Lerøy Aurora: 16.4 (15.4) Lerøy Midt: 16.2 (22.6) Lerøy Sjøtroll: 16.8 of which 7.9 was trout (18.8 of which 8.2 was trout) CATCH VOLUMES OF WILDFISH Total wild catch volumes in Lerøy Havfisk, measured in 1,000 tonnes: Q4 2025: 7.6 of which 2.7 of cod Q4 2024: 9.8 of which 3.1 of cod The catch volume for 2025 was 57,700 tonnes compared to 65,000 tonnes in 2024. The complete Q4 2025 report will be released on 24 February at 06:30 CET. Queries may be addressed...

Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering

Written by Customer Service on January 7, 2026. Posted in Public Companies.

BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the pricing of its underwritten public offering of 2,212,000 shares of its common stock at a public offering price per share of $260.00. The gross proceeds from the offering are expected to be approximately $575 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Praxis. All shares in the offering are being offered by Praxis. In addition, Praxis has granted the underwriters a 30-day option to purchase up to 331,800 additional shares of common stock at the public offering...

Soren Acquisition Corp. Announces the Pricing of $220,000,000 Initial Public Offering

Written by Customer Service on January 7, 2026. Posted in Public Companies.

Miami, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) — Soren Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, January 7, 2026, under the ticker symbol “SORNU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq...

Faraday Future Announces Stockholders’ Day Save the Date for January 7, 2026, in Las Vegas, NV to Coincide with the Annual CES

Written by Customer Service on January 7, 2026. Posted in Public Companies.

The program is intended to provide stockholders with the latest development progress, business updates, and strategic insights regarding both the FF and FX brands. A livestream of the event will be available here: https://www.ff.com/us/2026-CES/LAS VEGAS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that on January 7, 2026, coinciding with CES, Faraday Future will host its Stockholders’ Day, a key annual event dedicated to transparency, execution updates, and long-term value creation. This event will be livestreamed globally, allowing stockholders and others to join in real time as FFAI leadership shares strategic insights across Faraday Future (FF)...

Galantas Gold Announces Definitive Agreement to Acquire the Andacollo Oro Gold Project, Chile

Written by Customer Service on January 7, 2026. Posted in Mergers And Acquisitions.

TORONTO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V: GAL | AIM: GAL) (“Galantas” or the “Company”) is pleased to announce that on January 6, 2026 it has entered into a share purchase agreement (the “Agreement”) to acquire a 100% ownership interest in the Andacollo Oro Gold Project (the “Project”), located in the Coquimbo Region of central Chile (the “Transaction”). The Project is a past-producing, large-scale open pit heap leach gold operation with existing infrastructure, permits, and extensive historical technical data. The acquisition represents a significant strategic step for Galantas and is expected to constitute a Fundamental Acquisition under the policies of the TSX Venture Exchange (“TSXV”). Andacollo Oro Gold Project Overview The Project is located in the Coquimbo Region, Chile, approximately 55...

TTM Technologies, Inc. Announces Upcoming Conference Participation

Written by Customer Service on January 7, 2026. Posted in Public Companies.

SANTA ANA, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI), today announced that members of its management team will attend the following investor conferences:Edwin Roks, President and Chief Executive Officer, and Dan Boehle, Chief Financial Officer, will participate in the Needham Growth Conference on January 13th and 14th at the Lotte New York Palace Hotel in New York, with a presentation on January 13th at 8:45am Eastern Time.About TTMTTM Technologies, Inc. is a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies, and technologically advanced printed circuit boards (“PCB”s). TTM stands for time-to-market, representing how TTM’s time-critical, one-stop design, engineering and manufacturing...

HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China

Written by Customer Service on January 7, 2026. Posted in Public Companies.

— Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the Phase III registration part of the ESLIM-02 clinical trial of sovleplenib, a novel spleen tyrosine kinase (“Syk”) inhibitor, in adult patients with warm antibody autoimmune hemolytic anemia (“wAIHA”) in China has met its primary endpoint of durable hemoglobin (Hb) response rate within weeks 5 to 24 of treatment. Autoimmune hemolytic anemia (“AIHA”) is an autoimmune disorder characterized by the destruction of red blood cells (“RBCs”) due to the production of antibodies against RBC. The incidence of AIHA is estimated to be 0.8-3.0/100,000 adults per...

LGI Homes Reports 2025 Annual Home Closings and Sets Date for Fourth Quarter and Year End 2025 Earnings Conference Call

Written by Customer Service on January 6, 2026. Posted in Public Companies.

THE WOODLANDS, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced that it closed 569 homes in December 2025, including 35 currently or previously leased single-family rental homes. For the fourth quarter of 2025, the Company closed a total of 1,362 homes, including 61 currently or previously leased single-family homes. For the full year 2025, the Company closed a total of 4,788 homes including 103 currently or previously leased single-family rental homes. As of December 31, 2025, the Company was active in 144 selling communities. “Our teams across the country delivered an exceptional finish to the year,” said Eric Lipar, LGI Homes’ Chief Executive Officer and Chairman of the Board. “In December, we closed a total of 569 homes, a 43% increase over November, and achieved our fourth quarter closing...

Month: January 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals